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INTRODUCTION
The haematological profile of an individual is a simple,
fast, cost-effective and reliable indicator of general
health1,2. In the pregnant woman, the haematological
profile has the potential to impact pregnancy and the
outcome of that pregnancy3. Pregnancy is also
associated with various changes in hematological indices
such as decrease in red blood cell count and platelet
count1,4 and increase in white blood cell count5. Similarly,
haematological problems may be experienced by the
pregnant woman. Anaemia is the most common
haematological disorder in pregnancy and has the
potential for adverse pregnancy outcomes such as low
birth weight, miscarriages and low immunity6. Anaemia
in pregnancy results partly from a dilutional process
secondary to a discrepancy between the rate of increase
in plasma volume and that in red blood cell (RBC)
mass1,4. While the plasma volume increases by 25% -
80% between the sixth and twenty-fourth weeks of
gestation, the increase in RBC mass is approximately
30% and occurs between the twelfth and thirty-sixth
weeks of gestation1. Beside this physiological process,
other possible causes of maternal anemia that the care
provider must carefully evaluate for include nutritional
deficiencies such as folate and iron deficiency,
haemoglobinopathies7,8 and parasitic infections such
as malaria especially in highly endemic regions like
Nigeria8.
Similarly, pregnancy is associated with a drop in platelet
count, with many studies reporting approximately 10%
drop in platelet count by the end of pregnancy9,10.
However, the majority of pregnant women still have
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ABSTRACT
Introduction: Few studies have examined cytopaenia among HIV positive
pregnant women.
Objectives: To assess burden of  cytopaenia among HIV positive pregnant
women.
Methodology: This cross-sectional study of women on HAART <6months,
defined anemia as hematocrit <33%, leucopenia as total white blood cell count
<3,000 cells/mm3 and thrombocytopenia as absolute platelet count <100,000
cells/mm3. Univariate and bivariate analyses were performed.
Results: Over 8 years, of 1,197 women, the mean age was 29.02(±5.4) years and
mean gestational age 25.9(±8.1) weeks. Prevalence of anaemia was 76.8%,
leucopaenia 6.9% and thrombocytopenia 4.7%. The mean haematocrit was
28.5%(±4.5); median white blood count 5,500/mm3 ; median platelet count
200,000/mm3 and median CD4 323 cells/mm3.
Mean haematocrit was highest (29.7%±5.3) in women in the first trimester but
lowest (28.4% ±4.6) in women in second trimester (p=0.04). Compared with
earlier trimesters, women in the third trimester had higher median white blood
count (5,600 cells/mm3), higher neutrophil (61.0% ±11.2) but lower lymphocytes
(28.3%± 9.2) (p=0.18; 0.00, 0.00). Median absolute platelet count was highest
(206,000 cells/mm3) in the first trimester but lowest (195,000 cells/mm3) in
third trimester (0.04). Women with lower CD4 had higher prevalence of
cytopaenias.
Conclusion: Cytopaenias are not uncommon in this population especially with
lower CD4.
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platelet count within the normal range with most cases
being mild, and no adverse outcome for mother or
baby1. In contrast to these reductions, various studies
have reported that pregnancy is usually accompanied
by leukocytosis mainly due to neutrophils11,12. Several
changes have been reported in neutrophils during
pregnancy. They include impairment of  apoptosis due
to increased inflammatory response, reduced
chemotaxis and impaired respiratory burst 13,14. These
changes have been associated with a boost in non-
specific (innate) immunity and are thought to be a
compensation for the attenuation of specific immunity
in pregnancy15. The impairment of  specific immunity
correlates with a reduction in lymphocyte count in
pregnancy. Eosinophils and basophils also decline in
number with increasing gestational age5, 16.
The Human Immunodeficiency Virus (HIV) infection
is not uncommon in pregnancy in sub-Saharan Africa16.
HIV is associated with hematological abnormalities,
the most common manifestation being reduction in
and impaired function of all blood cell lines; red blood
cells (anemia), white blood cells (leucopenia or
neutropenia) and platelets (thrombocytopenia)
collectively called cytopenias.16 Cytopaenias increase in
frequency as HIV progresses and are often fatal
without intervention.17-19 Anemia is the most common
cytopaenia and its presence has been associated with
faster disease progression and an independent predictor
of  survival.17-21 The use of  highly active antiretroviral
therapy is associated with significant improvement in
patient survival and improvement in anaemia especially
severe anaemia18, 22, 23.
Studies about the prevalence and factors associated
with cytopaenia in patients living with HIV/AIDS has
largely been done among the general adult HIV
population17, 18, 21, 25-28. However, the magnitude of this
problem has not been adequately described among
HIV positive pregnant women.7, 29
Objectives: This study was designed to describe the
burden of and associated factors for cytopaenias
(anaemia, leucopaenia and thrombocytopaenia) at
different trimesters of pregnancy among HIV positive
pregnant women presenting for care at the University
College Hospital who were either HAART naïve or
on HAART for 6 months or less.
METHODOLOGY
This was a cross-sectional retrospective review of the
records of women who registered for care at the
Prevention of Mother-to-Child transmission (PMTCT)
unit of the University College Hospital (UCH), Ibadan.
The hospital offers PMTCT services supported by
the Government of Nigeria and the AIDS Prevention
Initiative in Nigeria (APIN) program. HIV positive
pregnant women access these services having being
referred from the UCH antenatal clinic, and other clinics
in the environs. PMTCT services provided include
administration of  anti-retroviral therapy for PMTCT,
infant feeding counseling and family planning
counseling.
At presentation, vital signs of patients are evaluated
and ill patients triaged accordingly. In line with the
National testing algorithm, patients presenting newly
with positive results are bled again and the HIV tests
repeated. Patients confirmed HIV positive are then
bled for selected hematological, immunological and
chemistry parameters. Post-test and follow-up
counselling is started immediately by trained
counsellors.  Clinics are conducted every day except
on Fridays. At subsequent clinics visits, patient will listen
to general health talks and then separated to specific
groups such as the PMTCT clinic where more targeted
information will be made available by PMTCT
counsellors. Pregnant women are then attended to by
physicians trained in administration of antiretrovirals
and PMTCT care. All pregnant women are eligible
for antiretroviral therapy as part of prophylaxis for
PMTCT. During the period under study, 1821 enrolled
in the PMTCT program.
Variables recorded at the first clinic visit include socio-
demographic characteristics and possible risk factors
for HIV acquisition. In addition, baseline laboratory
testing is conducted on all patients enrolling into the
program and includes measurement of CD4+ T
lymphocyte (CD4) count by flow cytometry and
plasma HIV RNA (viral load) by Roche Ampiclor
RNA PCR. Complete blood count and differential is
performed using Sysmex KX-21N, an automated 3-
part differential haematology analyzer (Sysmex
Corporation obe, Japan)30. The program maintains an
electronic database of the records of all patients
enrolled. The data used for this study was sampled
from the data base.
Anemia was defined as hematocrit less than 33%31.
Severity of anaemia was graded as mild (28-32%),
moderate (20-27%) and severe (< 20%)32. Other
cytopaenias were defined as follows: leucopenia if total
white blood cell count was less than 3,000 cells/mm3.16
Thrombocytopenia was defined as absolute platelet
count less than 100,000 cells/mm3.33,34 Severity of
thrombocytopenia was graded as mild (50, 000 – 99,
999 cells/mm3), moderate (20, 000- 49, 999 cells/
mm3) and severe (< 20, 000 cells /m mm3).33,34
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Statistical analysis
Continuous variables were summarized using means
(standard deviation) or medians as found appropriate
and categorical variables were summarized using
frequencies and percentages. Differences between
continuous variables were tested with student’s T-test,
ANOVA or Mann-Whitney test as appropriate while
categorical variables were compared using the chi
square test. The independent factors investigated
included demographic variables (e.g. age, marital status,
highest level of education attained) and clinical/
laboratory characteristics (e.g. CD4 cell count, viral load
etc). The association between these factors and presence
of the cytopaenias were evaluated.
Ethical Considerations
The antiretroviral treatment program was approved
by the University of Ibadan/University College
Hospital Ibadan Joint Institutional Review Board.
Informed consent forms were signed by all patients
during enrollment procedures. The electronic medical
record systems for the patient data are implemented
on a password-protected computer systems for the
purpose of privacy and confidentiality of data.
Patients’ folders containing case report forms are kept
in safe cabinets with locks in the medical records
section and access is restricted to  authorised persons
only.
RESULTS
The clinic records covering a 8-year period (January
1st 2006 and 31st December 2013) of one thousand,
eight hundred and twenty-one (1, 821) women enrolled
in the APIN-PMTCT clinic for care were reviewed.
Six hundred and twenty-four (624) women had missing
data and were excluded from further analysis. The data
of one thousand, one hundred and ninety-seven (1,
197) women are presented here. The mean age of the
women was 29.02 (± 5.4) years. The mean gestational
age at presentation was 25.9 (± 8.1) weeks. Slightly
over half (53.3%) presented in the third trimester of
pregnancy. About two-thirds (65.1%) of  the women
were between 25 and 34 years (Table 1). More than
half  (63.5%) had had more than 6 years of  formal
education. Majority (77.5%) were either engaged in
one form of  buying and selling or in low skilled
occupation such as farming. Almost all the patients
(92.1%) were married. The burden of cytopaenias is
as shown in Figure 1. While over three quarters (76.8%)
were anaemic, leucopaenia was observed in 6.9% of
the patients and less than five percent (4.7%) had
thrombocytopaenia.
Table 2 shows the distribution of  haematological
variables by trimester. Overall, the mean haematocrit
value for the women was 28.5% (± 4.5), the median
Trimesters
Variable All (1197) 1st (110) 2nd (449) 3rd (638) p value
Age
<20 years 31 (2.6%) 2 (7.1%) 7 (23.8%) 22 (69.1%) 0.748
20-24 years 205 (17.1%) 20 (9.6%) 75 (36.8%) 110 (53.6%)
25-29 years 415 (34.7%) 36 (8.8%) 163 (39.2%) 216 (52.0%)
30-34 years 364 (30.4%) 34 (9.3%) 140 (38.4%) 190 (52.3%)
35-39 years 145 (12.1%) 15 (10.5%) 54 (37.2%) 76 (52.3%)
≥ 40 years 37 (3.1%) 3 (8.0%) 10 (28.0%) 24 (64.0%)
Formal Education
Nil 95 (7.9%) 11 (11.2%) 33 (35.2%) 51 (53.6%) 0.501
6 years or less 342 (28.6%) 28 (8.4%) 129 (37.6%) 185 (54.0%)
7-12 years 504 (42.1%) 42 (8.3%) 186 (37.0%) 276 (54.7%)
more than 12 years 256 (21.4%) 26 (10.1%) 101 (39.4%) 129 (50.5%)
Occupation
Unemployed/trainee/student 93 (7.8%) 10 (10.6%) 38 (40.7%) 45 (48.7%) 0.629
Low skilled/farming 273 (22.8%) 25 (9.2%) 97 (35.5%) 151 (55.3%)
Trading (Buying and selling) 655 (54.7%) 59 (9.0%) 259 (39.5%) 337 (51.5%)
Government worker (junior ) 63 (5.3%) 4 (6.9%) 22 (34.3%) 37 (58.8%)
Government worker (senior) 29 (2.4%) 4 (13.2%) 12 (42.1%) 13 (44.7%)
Housewife 84 (7.0%) 9 (11.0%) 29 (34.0%) 46 (55.0%)
Marital Status
Married 1102 (92.1%) 97 (8.8%) 409 (37.1%) 596 (54.1%) 0.04
Not married 95 (7.9%) 13 (14.0%) 38 (39.5%) 44 (46.5%)
Table 1: Distribution of  selected maternal socio-demographic characteristics by trimester
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Trimesters
Variable All (1197) 1st (110) 2nd (449) 3rd (638) p value
Haematocrit 28.5 29.7 28.4 28.5 0.04
(± 4.5) (± 5.3) (± 4.6) (± 4.3)
Degree of anaemia
Nil anaemia 283 (23.7%) 43 (39.3%) 105 (23.5%) 135 (21.5%) 0.00
Mild anaemia 657 (54.9%) 50 (44.9%) 236 (52.6%) 371 (57.9%)
Moderate anaemia 205 (17.1%) 10 (9.0 %) 87 (19.4%) 108 (16.8%)
Severe anaemia 52 (4.3%) 7 (6.7%) 21 (4.6%) 24 (3.8%)
WBC (cells/mm3) 5,500 5, 400 5,400 5,600 0.18
(4.0-19,800) (1,200-9, 600) (4.0-17, 020) (4.0-13, 000)
Neutrophil (%) 60.5 55.2 60.9 61.0 0.00
(±11.8) (±14.9) (±10.2) (±11.2)
Lymphocyte (%) 28.8 32. 8 28.9 28.3 0.00
(±9.7) (±11.2) (±9.6) (±9.2)
Platelet 200.0 206.5 203.0 195.5 0.04
(X1000 cells/mm3) (13.5- 888.0) (24.0-674.0) (22.0-832.0) (18.8-686.0)
Degree of
Thrombocytopenia
Normal values 1141 (95.3%) 104 (95.6%) 434 (96.7%) 603 (94.3%) 0.22
Mild 42 (3.5%) 3 (2.2%) 13 (2.8%) 26 (4.4%)
Moderate 12 (1.0%) 3 (2.2 %) 2 (0.5%) 7 (1.1%)
Severe 2 (0.2%) 0 (0.0%) 0 (0.0%) 2 (0.2 %)
CD4 count 323 294 323 333 0.02
(0-3102) (0-1289) (1-1431) (0-1730)
Log viral load 4.1 4.2 4.1 4.0 0.05
(±1.1) (±1.2) (±1.1) (±1.1)
Table 2: Distribution of  hematological variables by trimester
Fig. 1: Prevalence of  various cytopaenias among HIV positive pregnant women
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white blood cell count of the women was 5, 500 cells/
mm3 and the median total platelet count was 200, 000/
mm3 (13, 500 to 888, 000). The median CD4 count at
presentation was 323 cells/mm3 (range 0-3102) and
mean log viral load was 4.1 (± 1.1). The mean
haematocrit was observed to be highest in women
who presented in the first trimester of pregnancy but
lowest in women who presented for care in the second
trimester of  pregnancy. These differences were
statistically different (p= 0.04). Most of the women
with anaemia had mild anaemia (54.9%). Women who
presented for care in the third trimester of pregnancy
had higher median white blood cell count than women
who presented at earlier trimesters of  pregnancy.
Similarly, these women also had higher percentage of
neutrophil but lower percentage of  lymphocytes. These
differences were statistically significant (p=0.001 and
0.001 respectively). Finally, the absolute platelet count
was observed to be highest in women who presented
in the first trimester of pregnancy but lowest in women
who presented for care in the third trimester of
pregnancy. The proportion of  women with platelet
count in the thrombocytopaenic range, was highest in
the women who presented in the third trimester of
pregnancy although these differences were not
statistically significant (p=0.22).
Table 3 compares women with cytopaenia and
women without cytopaenia. The women with anaemia
were more advanced in their pregnancies and had
fewer years of education. These differences were
statistically significant (p=0.01 and 0.02 respectively).
Similarly, women with thrombocytopaenia had fewer
years of education (p=0.02). Age and marital status













Mean age 28.8 (± 4.8) 28.9 (± 5.3 28.8 (± 5.2) 29.7 (± 5.1) 28.8 (± 5.2) 29.7 (± 5.5)
p value 0.96 0.23 0.12
Mean gestational age (weeks) 25.1 (± 8.9) 26.7 (± 7.6) 26.2 (± 7.9) 28.4 (± 8.2) 26.3(± 7.8) 26.2 (± 7.8)










































































































































p value 0.00 0.74 0.45
Table 3: Comparing characteristics of  women with cytopaenias and women without cytopaenias
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had no impact on the prevalence of  cytopaenias.
Women with lower CD4 count had higher prevalence
of  all cytopaenias. Apart from anaemia, increasing viral
load did not appear to have any impact on prevalence
of leucopaenia and thrombocytopaenia.
DISCUSSION
The aim of this study was to describe the burden of
and associated factors for cytopaenias at different stages
of  pregnancy. We were also able to evaluate the effect
of the immunologic and virologic status of the
women on these cytopaenias among HIV positive
pregnant women. HIV has profound effect on
haemopoiesis thus blood cell counts are useful in the
evaluation, management and monitoring of HIV
positive pregnant women. The most prevalent
cytopaenia observed among our patients was anaemia
which occurred in about three quarters (76.8%) of the
women followed by leucopenia (6.9%). Higher
proportion of anaemia and thrombocytopenia were
observed in women who presented at later trimesters
of  pregnancy. Similarly, higher values of  white blood
cell count was observed in women who presented at
later gestational age of  pregnancy, in contrast to non-
pregnant HIV positive women in whom neutropaenia
is prominent occurring in 10-15% of patients 25.
The mean haematocrit in our group of women was
28.5% which is similar to a value of 29.3% among
HIV positive pregnant women in Abidjan reported
by Rosa Ramon7. However, this is lower than the values
of 30.2% reported by Akinbami et al, 31.3% by
Akingbola et al and 34.9 % by Purohit among the
general obstetric population. These studies were done
in Lagos (Nigeria), Ibadan (Nigeria) and the West Indies
respectively.1,31,32 We noted that women in the first
trimester of pregnancy had the highest levels of
haematocrit compared to women either in the second
or third trimesters. This is similar to the pattern
observed in pregnant HIV negative women by
Akinbami et al, Akingbola et al and Purohit et al .1,31,32
Physiological anaemia may account for this pattern.
During the second trimester of  pregnancy, additional
progesterone and estrogen are secreted by the placenta
causing a release of  renin from the kidneys. Stimulation
of the Renin-aldosterone angiotensin system will cause
sodium retention and increased plasma volume and
consequently a fall in maternal haematocrit.33 In late
pregnancy, however, plasma volume increases at a
slower rate and this accounts for the slight rise in
haematocrit that is usually observed in the third
trimester 2. A different pattern of rise then fall towards
the end of  pregnancy was observed by Osonuga et al
and Obeagu et al 34, 35. Smaller sample size by the latter
two study groups may account for this discrepancy.
The prevalence of anaemia in this group of HIV
positive pregnant women was 76.8%. This is higher
than 3% reported from a study in Korea25, 11.9% in a
multi-country study36, 18.9% from a study in rural
Uganda37 and 37.7% in a Brazilian study.21 Factors
associated with anaemia in our study include fewer
years of  formal education, higher gestational age and
advancing degree of immune suppression. While
females may particularly be more likely to have
anaemia (as a result of additional demands during
pregnancy and menstrual loss)36-38 increasing immune
suppression (measured by CD4 cell count) has also
been reported as a risk factor for anaemia.25,39 The
etiology of  anemia in HIV-infection is multifactorial.
The anemia is often the normocytic normochromic
anemia of chronic inflammation due to reduced
erythropoietin production and will resolve rapidly with
the use of  anti-retrovirals.40 Other causes include
infiltrative conditions of  the bone marrow (e.g.
neoplasms or infection including HIV itself)41,
hemolytic causes (e.g. red blood cell autoantibodies)42
and nutritional deficiencies43. In the context of HIV
infection, anaemia has often been implicated as an
independent marker of HIV disease progression and
mortality.19, 44 Indeed, women with severe anaemia at
baseline may have a 13 times greater risk of death
during the first year of  ART.13 Indeed, given the
background high maternal mortality ratio in
populations where HIV is often prevalent, such as
Nigeria,45 it is even more pertinent that care providers
identify and vigorously manage HIV positive pregnant
women who are also anaemic in order to prevent
maternal mortalities.
The median WBC count observed in this group of
HIV positive pregnant women was 5,500 cells/mm3,
which is lower than the values reported by Akinbami
et al, Akingbola et al and Obeagu et al for HIV negative
pregnant women in Nigeria.1,31,35 The value is however
similar to that reported by Ramon et al among HIV
positive pregnant women7 but higher than a report
from Uganda among the adult HIV positive
population16. The white blood cell count was observed
to be higher in women with more advanced
pregnancies like the pattern observed by several
workers.1,12,31,32,34,35 The increase in WBC observed in
pregnancy has been attributed to an increase in
neutrophils and maybe the result of redistribution of
the WBCs between the marginal and circulating pools.12
The mean neutrophil percentage was observed to be
60.5%. Compared to the general obstetric population,
our observed value is similar to the value of  62.6%
reported from Abia35, higher than 52.9% from Ogun
state34 both in Nigeria but lower than 70.0% reported
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by Purohit in the West Indies.32 Among the HIV
positive population however, Ramon reported a similar
value of 61.4% for pregnant women7 while Dikshit
reported a higher value of 70.6% among the adults45.
Similarly, higher percentage of  neutrophils was
observed in women who presented later in pregnancy.
This is because pregnancy imposes an inflammatory
response in the woman resulting in significant increment
in total white blood cell (WBC) and neutrophil counts
in all trimesters of gestation. In addition, increase in
the circulating level of granulocyte monocyte colony
stimulating factor, a growth hormone for leucocyte
has been reported.46 On the other hand, with
leucopenia, neutropenia is the most clinically relevant
subtype because it is a good indicator of the risk of
infection. The presence of neutropenia in HIV infection
exacerbates the susceptibility to infections such as
bacteraemia, meningitis but particularly to invasive
fungal infections.47 Conflicting patterns have however
been reported by some other workers.32,34,35
The mean lymphocyte percentage observed was 28.8%
with lower values in women with more advanced
pregnancies. This value is lower than that reported for
HIV negative pregnant women by Osonuga et al 34
and Obeagu et al 35 but higher than 22.8% reported by
Purohit.32 It is however lower than the value of 32.8%
reported by Ramon et al among HIV positive pregnant
women.7 HIV infection in these women may not
completely explain the fall in lymphocyte count
towards the end of  pregnancy. A report of  similar
dynamics in the lymphocyte count throughout
pregnancy was reported in HIV negative pregnant
women in the same hospital, contrary to the finding
of Osonuga et al and Obeagu et al who noted a rise
then fall.31,34,35 These contradictory findings in the
dynamics of lymphocyte count throughout pregnancy
has been explained in relation to the mechanism which
prevent rejection of the fetal allograft.15
The median platelet count in all the women was
observed to be 200, 000 cells/ml with lower values in
women with more advanced pregnancies. This value
is lower than values reported by Akinbami et al in
Lagos, Akingbola in Ibadan and Purohit in West Indies.1,
31, 32 It is however higher than the value of 198,000
cells/ml reported by Obeagu et al in Abia.35 All of
these authors worked with the general obstetric
population. Similarly, slightly higher figures were
reported by several workers who evaluated HIV
positive individuals. These include Ramon et al 7 (225,
000 cells/mm3 among pregnant women) and Dikshit,
de Santis and Kyeyune (reported 249,500 cells/mm3,
227, 000 cells/mm 3 and 244,000 cells/mm 3
respectively among the HIV positive adult
population).17,21,45 After anemia, thrombocytopenia is
the second most common hematologic abnormality
that occurs during pregnancy. Similar to our
observations on the platelet count dynamics in this
study, Akinbami et al and Akingobla et al in their studies
also reported a fall in platelets count in later trimesters
of  pregnancy.1, 31 This drop in platelet count has been
attributed to a dilutional effect and accelerated
destruction of platelets passing over the scarred
trophoblastic surface of the placenta.48 Other possible
causes of thrombocytopenia in pregnancy include
hypertensive disorders of pregnancy (15-20%), an
immune related process (3-4%) or occasionally rare
constitutional thrombocytopenia (1-2%).49
Cytopenias, in particular anaemia, in HIV infected
individuals have been shown to predict disease
progression and mortality.19,21,22,50 The causative role
of HIV in vivo in altering the bone marrow micro-
environment to inhibit haematopoiesis and directly
resulting in cytopenia is uncertain51, 52. However,
cytopenia occur more frequently with advanced HIV
or as viral replication persists and patients may present
with multiple cytopenias.20,53 The highest rates of
cytopaenia have been noted to occur in patients with
advanced HIV (CD4 count <200). 21,38,45 The
association of low CD4 cell count with cytopaenia
may be due to the dysregulatory effect of HIV on the
function of early haematopoietic progenitor cells
through the viral accessory protein Negative factor (N.
F.)20.
The main limitation of this analysis is that it is a cross
sectional retrospective review of records which makes
determination of  temporal relationship between
cytopaenia, and associated factors difficult.
Furthermore, we did not evaluate for other causes of
cytopaenias e.g. malaria, hemoglobinopathies,
nutritional deficiencies e.t.c., prevalent in this
population. These causes are not part of the protocol
of care in the clinic where this review was conducted.
In conclusion, this study provides an opportunity to
describe the burden and associated factors for
cytopaenias in HIV positive pregnant women.
Cytopaenias are not uncommon in this group of
pregnant women. Anaemia was more common than
leucopaenia or thrombocytopaenia in this group of
women and requires attention given its prognostic role
in HIV disease mortality and the background history
of high maternal mortality in the population studied.
Cytopaenias were more prevalent with lower CD4.
HAART has been shown to satisfactorily correct this
as its administration is associated with increase in CD4
cell count and a reversal of the dysregulatory effect
of HIV on the function of early haematopoietic
progenitor cells which is responsible for the cytopaenia.
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